Sensome today announced the publication of first-in-human results from the CLOT OUT study evaluating its Clotild smart guidewire system. Findings published in the Journal of Neurointerventional Surgery demonstrated, for the first time, the ability of Clotild to accurately characterize clot from inside a fully occluded brain vessel. The study … [Read more...] about Sensome reports positive findings for clot-sensing guidewire
Sensome
Sensome reports positive proof-of-concept outcomes in robotic thrombectomy
Sensome today announced proof-of-concept cases using its Clotild smart guidewire system with robotic thrombectomy technology. The company said the cases using Clotild were performed with commercial and next-generation robotic systems from Robocath. This effort demonstrated the feasibility of Paris-based Sensome's smart guidewire technology with … [Read more...] about Sensome reports positive proof-of-concept outcomes in robotic thrombectomy
Sensome data supports clot-sensing guidewire
Sensome today announced positive results from two studies of its Clotlid smart guidewire system for identifying blood clots. Outcomes highlighted Clotlid's ability to successfully identify "fresh" clot — thrombus rich in red blood cells (RBCs) — in peripheral artery disease (PAD) and differentiate it from other tissue encountered during PAD … [Read more...] about Sensome data supports clot-sensing guidewire
